Literature DB >> 17724720

Family history of urogenital cancers in patients with bladder, renal cell and prostate cancers.

Giorgia Randi1, Claudio Pelucchi, Eva Negri, Renato Talamini, Carlotta Galeone, Silvia Franceschi, Carlo La Vecchia.   

Abstract

Family history of urogenital cancers has been associated with an increased risk of cancer at the same sites. To evaluate the risks of bladder, prostate and renal cell neoplasms for family history of urogenital cancers in first-degree relatives, we analysed data from a case-control study conducted in northern Italy between 1985 and 1992 and including a total of 1,356 incident, histologically confirmed cancer cases: 727 bladder, 348 renal cell and 281 prostate cancer cases. Controls were 1,067 patients admitted to the same network of hospitals for acute, nonneoplastic conditions. Unconditional logistic regression was used to estimate odds ratios (ORs) of urogenital cancers, adjusting for age, sex, study centre, education, body mass index, smoking habit, alcohol consumption and number of brothers and, where appropriate, sisters. ORs of urogenital cancers for subjects with at least 1 first-degree relative with cancer at the same site were 6.1 [95% confidence interval (CI), 2.3-16.6] for bladder, 2.0 (95% CI: 0.6-6.2) for renal cell and 2.0 (95% CI: 0.9-4.1) for prostate cancer. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17724720     DOI: 10.1002/ijc.23037

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Family history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis.

Authors:  Jessica Clague; Jie Lin; Adrian Cassidy; Surena Matin; Nizar M Tannir; Pheroze Tamboli; Christopher G Wood; Xifeng Wu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-24       Impact factor: 4.254

2.  Prevalence of family history of breast, colorectal, prostate, and lung cancer in a population-based study.

Authors:  P L Mai; L Wideroff; M H Greene; B I Graubard
Journal:  Public Health Genomics       Date:  2010-04-09       Impact factor: 2.000

3.  An integrative approach for identification of smoking-related genes involving bladder cancer.

Authors:  Fang Gao; Huiqin Li; Zhenguang Mao; Yanping Xiao; Mulong Du; Shizhi Wang; Rui Zheng; Zhengdong Zhang; Meilin Wang
Journal:  Arch Toxicol       Date:  2022-10-12       Impact factor: 6.168

Review 4.  Familial and genetic risk of transitional cell carcinoma of the urinary tract.

Authors:  Christine M Mueller; Neil Caporaso; Mark H Greene
Journal:  Urol Oncol       Date:  2008-06-18       Impact factor: 3.498

5.  Family history of cancer and renal cell cancer risk in Caucasians and African Americans.

Authors:  S Karami; K Schwartz; M P Purdue; F G Davis; J J Ruterbusch; S S Munuo; S Wacholder; B I Graubard; J S Colt; W-H Chow
Journal:  Br J Cancer       Date:  2010-05-04       Impact factor: 7.640

6.  Contemporary epidemiology of renal cell cancer.

Authors:  Wong-Ho Chow; Susan S Devesa
Journal:  Cancer J       Date:  2008 Sep-Oct       Impact factor: 3.360

7.  An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis.

Authors:  Michał Kiciński; Jaco Vangronsveld; Tim S Nawrot
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

8.  Identification of Genetic Risk Factors for Familial Urinary Bladder Cancer: An Exome Sequencing Study.

Authors:  Alexander Pemov; Talia Wegman-Ostrosky; Jung Kim; Stella Koutros; Brenna Douthitt; Kristine Jones; Bin Zhu; Dalsu Baris; Molly Schwenn; Alison Johnson; Margaret R Karagas; Brian D Carter; Marjorie L McCullough; Maria Teresa Landi; Neal D Freedman; Demetrius Albanes; Debra T Silverman; Nathaniel Rothman; Neil E Caporaso; Mark H Greene; Joseph F Fraumeni; Douglas R Stewart
Journal:  JCO Precis Oncol       Date:  2021-12-22

9.  Modeling the Complex Exposure History of Smoking in Predicting Bladder Cancer: A Pooled Analysis of 15 Case-Control Studies.

Authors:  Frits H M van Osch; Jelle Vlaanderen; Sylvia H J Jochems; Cristina Bosetti; Jerry Polesel; Stefano Porru; Angela Carta; Klaus Golka; Xuejuan Jiang; Mariana C Stern; Wei-De Zhong; Eliane Kellen; Hermann Pohlabeln; Li Tang; James Marshall; Gunnar Steineck; Margaret R Karagas; Kenneth C Johnson; Zuo-Feng Zhang; Jack A Taylor; Carlo La Vecchia; Richard T Bryan; Frederik J van Schooten; Anke Wesselius; Maurice P Zeegers
Journal:  Epidemiology       Date:  2019-05       Impact factor: 4.822

10.  Bladder cancer epidemiology and genetic susceptibility.

Authors:  Haiyan Chu; Meilin Wang; Zhengdong Zhang
Journal:  J Biomed Res       Date:  2013-03-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.